Immunogen, Inc.

NASDAQ:IMGN   3:59:56 PM EDT
4.32
-0.05 (-1.14%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)939.67M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$16.18 Million
Adjusted EPS-$0.21
See more estimates
10-Day MA$3.92
50-Day MA$4.17
200-Day MA$5.43
See more pivots

Immunogen, Inc. Stock, NASDAQ:IMGN

830 Winter Street, Waltham, Massachusetts 02451-1477
United States of America
Phone: +1.781.895.0600
Number of Employees: 106

Description

ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA.